Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Popat

Showing results (121-130 of 273) with videos related to

Pageof 28
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 31, 2015
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)Fatma Abdelraouf, Egbert Smit, Baktiar Hasan, et al.
The Oncologist|November 4, 2020
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team ApproachSanjay Popat, Neal Navani, Keith M Kerr, et al.
Clinical Lung Cancer|November 1, 2023
TARGET: A Phase II, Open-Label, Single-Arm Study of 5-Year Adjuvant Osimertinib in Completely Resected EGFR-Mutated Stage II to IIIB NSCLC Post Complete Surgical ResectionRoss Andrew Soo, Filippo de Marinis, Ji-Youn Han, et al.
Scandinavian Journal of Gastroenterology|September 14, 2007
Gut microflora associated characteristics in first-degree relatives of children with celiac diseaseBo Tjellström, Lars Stenhammar, Lotta Högberg, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2014
Afatinib in the treatment of EGFR mutation-positive NSCLC--a network meta-analysisSanjay Popat, Tony Mok, James Chih-Hsin Yang, et al.
Plos One|November 26, 2019
A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesotheliomaAnna Minchom, Daisy Mak, Ranga Gunapala, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2022
Lung Cancer in the United KingdomNeal Navani, David R Baldwin, John G Edwards, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2014
A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor materialJohn Le Quesne, Manisha Maurya, Slaveya G Yancheva, et al.
Carcinogenesis|November 25, 2003
Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin geneAthena Matakidou, Nancy Hamel, Sanjay Popat, et al.
Cancer Treatment and Research Communications|December 14, 2020
Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experienceWanyuan Cui, Nadia Yousaf, Jaishree Bhosle, et al.
Pageof 28

Showing results (121-130 of 273) with videos related to

Sort By:
Pageof 28
European Journal of Cancer (Oxford, England : 1990)|December 31, 2015
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)Fatma Abdelraouf, Egbert Smit, Baktiar Hasan, et al.
The Oncologist|November 4, 2020
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team ApproachSanjay Popat, Neal Navani, Keith M Kerr, et al.
Clinical Lung Cancer|November 1, 2023
TARGET: A Phase II, Open-Label, Single-Arm Study of 5-Year Adjuvant Osimertinib in Completely Resected EGFR-Mutated Stage II to IIIB NSCLC Post Complete Surgical ResectionRoss Andrew Soo, Filippo de Marinis, Ji-Youn Han, et al.
Scandinavian Journal of Gastroenterology|September 14, 2007
Gut microflora associated characteristics in first-degree relatives of children with celiac diseaseBo Tjellström, Lars Stenhammar, Lotta Högberg, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2014
Afatinib in the treatment of EGFR mutation-positive NSCLC--a network meta-analysisSanjay Popat, Tony Mok, James Chih-Hsin Yang, et al.
Plos One|November 26, 2019
A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesotheliomaAnna Minchom, Daisy Mak, Ranga Gunapala, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2022
Lung Cancer in the United KingdomNeal Navani, David R Baldwin, John G Edwards, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2014
A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor materialJohn Le Quesne, Manisha Maurya, Slaveya G Yancheva, et al.
Carcinogenesis|November 25, 2003
Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin geneAthena Matakidou, Nancy Hamel, Sanjay Popat, et al.
Cancer Treatment and Research Communications|December 14, 2020
Real-world outcomes in thoracic cancer patients with severe Acute respiratory syndrome Coronavirus 2 (COVID-19): Single UK institution experienceWanyuan Cui, Nadia Yousaf, Jaishree Bhosle, et al.
Pageof 28